Sorafenib use in hepatitis B virus- or hepatitis C virus-related hepatocellular carcinoma: A propensity score matching study.
Kaohsiung J Med Sci
; 37(10): 894-902, 2021 Oct.
Article
in En
| MEDLINE
| ID: mdl-34166565
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
Main subject:
Hepatitis B virus
/
Hepacivirus
/
Carcinoma, Hepatocellular
/
Sorafenib
/
Liver Neoplasms
Language:
En
Journal:
Kaohsiung J Med Sci
Year:
2021
Type:
Article
Affiliation country:
Taiwan